Gujarat Technological University Student list for M.Pharm ...

Sr.

No.Date MAP_NUMBER Student_name sub code

Branch_

Code

College

_Code

Branch_

TypeBranch_name Micro

Other_

MicroDP1_TITLE Guide Name

1 29-April-2019 172020820002 Vashi Janu Alkeshkumar MRW403P 20 202 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND OPTIMIZATION OF ILEO-COLONIC

TARGETED MUCOADHESIVE MICROSPHERES CONTAINING DR. SAIKAT PANDE

2 02-May-2019 172020826001 PATEL KAJAL DHANJIBHAI MRW403P 26 202 MP Pharmacognosy HERBAL RESEARCHPHARMACOGNOSTICAL, PHYTOCHEMICAL AND DIURETIC

ACTIVITY OF RORIPPA INDICADR.(MRS) MONA KUKKAR

3 29-April-2019 172020820001PATEL VISHAKHAKUMARI

MAHESHKUMARMRW403P 20 202 MP Pharmaceutics

NANO SUSPENSION/EMULSION,

SEDDS, LIPID BASED DDS

SOLID SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM: A

NOVEL APPROACH FOR THE ORAL ADMINISTRATION OF DR. AJAY SOLANKI

4 29-April-2019 172020824001 PATEL TWINCYBEN KIRITBHAI MRW403P 24 202 MPPharmaceutical

Quality AssuranceOTHER (KINDLY SPECIFY)

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING

HPTLC METHOD FOR PERAMPANEL IN IT’S TABLET DOSAGE

FORM

DR. RAJENDRA MEHTA

5 29-April-2019 172020824002 THESIYA KRISHNABEN BHARATKUMAR MRW403P 24 202 MPPharmaceutical

Quality AssuranceSTABILITY STUDIES


HPTLC METHOD FOR RIOCIGUAT IN TABLET DOSAGE FORM

DR.(MRS) ANANDKUMARI

D CAPTAIN

6 30-April-2019 172020822001 TARAPRA ANKITABEN MOHANBHAI MRW403P 22 202 MPPharmaceutical

ChemistryOTHER (KINDLY SPECIFY)

DESIGN, SYNTHESIS AND ANTI-ALZHEIMER ACTIVITY OF

NOVEL CHROMAN DERIVATIVESDR. VIPUL VAGHELA

7 29-April-2019 172050820001 Joshi Deepika Manohar MRW403P 20 205 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FABRICATION AND IN VITRO EVALUATION OF FEBUXOSTAT

TABLET FOR OBTAINING BIPHASIC DRUG RELEASE PROFILEDR. MUKESH GOHEL

8 29-April-2019 172050820005 PATEL KAJOLBEN ARUNKUMAR MRW403P 20 205 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,

TOPICAL, HYDROGELS NASAL

PREPARATION AND CHARACTERIZATION OF TOPICAL

FORMULATION CONTAINING QUERCETIN AS WOUND DR. VAISHALI THAKKAR

9 29-April-2019 172050820009 Udhwani Nikita Haresh MRW403P 20 205 MP Pharmaceutics MULTIPARTICULATE

EXPLORATION OF RESEARCH OPPORTUNITIES IN THE

DEVELOPMENT OF IMMEDIATE RELEASE MINI-TABLETS OF

CILOSTAZOL

DR. MUKESH C. GOHEL

10 29-April-2019 172050820010 Vyas Shubham Sanjaykumar MRW403P 20 205 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DEVELOPMENT AND CHARACTERIZATION OF

ROXITHROMYCIN TOPICAL GELDR. VAISHLAI THAKKAR

11 29-April-2019 172050820002 MALAV RUPESH MANIAR MRW403P 20 205 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE EXCIPIENTS AND

AT

DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF

DIBASIC CALCIUM PHOSPHATE DIHYDRATE FOR THE

FORMULATION OF SOLID ORAL DOSAGE FORM

DR. MUKESH GOHEL

12 29-April-2019 172050820011 MS. PAROMITA SAHA MRW403P 20 205 MP PharmaceuticsCO PROCESSED, DC,


MINIMIZATION OF RETARDATION OF DRUG RELEASE FROM

HARD GELATIN CAPSULE DR. MUKESH C. GOHEL

13 29-April-2019 172050820008 Tadvi Gaureeben Rajeshbhai MRW403P 20 205 MP Pharmaceutics OTHER (KINDLY SPECIFY)DEVELOPMENT OF DISINTEGRATION CONTROLLED MATRIX

TABLET OF GLIBENCLAMIDEMS. DIPIKA CHAVDA

14 29-April-2019 172050820003 Panchal Punam Ketankumar MRW403P 20 205 MP Pharmaceutics MISCELANEOUSDEVELOPMENT AND EVALUATION OF GLIPIZIDE PASTILLES

BY EMPLOYING QUALITY BY DESIGN APPROACHMR. HARDIK RANA

15 29-April-2019 172050820004 Patel Ashviniben Dilipbhai MRW403P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST

DISPERSIBLE/DISSOLVI

DEVELOPMENT AND OPTIMIZATION OF ORAL SPRAY OF

TADALAFIL EMPLOYING QbD APPROACHMR. HARDIK RANA

16 29-April-2019 172050820006 Raut Jignasaben Devrambhai MRW403P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DISSOLUTION ENHANCEMENT OF BOSWELLIA SERRATA

EXTRACT BY LIQUISOLID APPROACH MS. DIPIKA CHAVADA

17 29-April-2019 172050820007 Tadvi Arunaben Kanchanbhai MRW403P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DISSOLUTION ENHANCEMENT OF BICALUTAMIDE BY

DEVELOPING SOLID DISPERSION EMPLOYING MICROWAVE DR. VAISHALI T. THAKKAR

18 29-April-2019 172050824004 PATEL KRISHNA SURESHBHAI MRW403P 24 205 MPPharmaceutical


FORMULATION DEVELOPMENT AND SIMULTANEOUS

ESTIMATION OF TADALAFIL AND DAPOXETINE

HYDROCHLORIDE IN NEWER COMBINED DOSAGE FORM

DR. PURVI A. SHAH

19 29-April-2019 172050824006 Shah Nejal Nitinkumar MRW403P 24 205 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD

FOR QUANTIFICATION OF NEPAFENAC IN NEWER

OPTIMIZED OPHTHALMIC FORMULATION

DR. KALPANA G. PATEL

GTU/S19/DP-2/MPH-3074 Date:- 20-04-2019

Student list for M.Pharm Sem 4 (Regular) Dissertation Phase-2 (DP-2) (Summer 2019)Gujarat Technological University

20 02-May-2019 172050825001 Himanshi Ravinder Kaul MRW403P 25 205 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF ANTI-OBESITY ACTIVITY OF CORIANDRUM

SATIVUM IN RAT MODELDR. TEJAL R. GANDHI

21 02-May-2019 172050825003 NAIR KARISHMA JAYPRAKASH MRW403P 25 205 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF NOX-4 INHIBITOR -QUERCETIN IN 10 WEEKS

RAT MODEL OF DIABETIC NEPHROPATHYDR. TEJAL R. GANDHI

22 29-April-2019 172050824002 Chunara Kiranben Rameshchandra MRW403P 24 205 MPPharmaceutical

Quality AssuranceSIMULTENEOUS ESTIMATION

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS

FOR SIMULTANEOUS ESTIMATION OF EMPAGLIFLOZIN AND DR. PURVI A. SHAH

23 29-April-2019 172050824003 DESAI JINAL HEMANTKUMAR MRW403P 24 205 MPPharmaceutical

Quality AssuranceHERBAL


FOR ESTIMATION OF BERBERINE AND RETINOIC ACID IN

NOVEL HERBAL FORMULATION USING EXPERIMENTAL

DR.KALPANA G. PATEL

24 29-April-2019 172050824007 Shah Nischay Sunil MRW403P 24 205 MPPharmaceutical


FORMULATION DEVELOPMENT AND ANALYTICAL METHOD

DEVELOPMENT FOR FLUCONAZOLE AND QUERCETIN IN MR. HITESH G. RAVAL

25 02-May-2019 172050825004 PATEL ANJALIBEN BIPINBHAI MRW403P 25 205 MP Pharmacology RENAL DISORDERS

EVALUATION OF SAPONIN RICH FRACTION OF FOLK

MEDICINES FOR THE TREATMENT OF KIDNEY STONE

DISEASES

DR. TEJAL R. GANDHI

26 02-May-2019 172050825005 Patel Priyankaben Pankajbhai MRW403P 25 205 MP Pharmacology CVS DISORDER

CARDIOPROTECTIVE EFFECT OF FOENICULUM VULGARE IN

ISOPROTERENOL INDUCED MYOCARDIAL INFARCTION IN

EXPERIMENTAL RATS

DR. TEJAL R. GANDHI

27 02-May-2019 172050825006 Prajapati Riddhi Bansilal MRW403P 25 205 MP Pharmacology RENAL DISORDERS

EVALUATION OF FLAVANOID RICH FRACTION OF FOLK

MEDICINES IN EXPERIMENTALLY INDUCED UROLITHIASIS IN

RAT MODEL

DR. TEJAL R. GANDHI

28 02-May-2019 172050825007 PUROHIT MILAP DAKSHESHKUMAR MRW403P 25 205 MP Pharmacology CVS DISORDERCARDIOPROTECTIVE EFFECT OF LANSOPRAZOLE IN

EXPERIMENTALLY INDUCED CARDIAC FIBROSISDR. SARIKA JOHARI

29 02-May-2019 172050825008 SINGH ANJALI JEEVANKUMAR MRW403P 25 205 MP Pharmacology CVS DISORDEREFFECT OF SERCA2 CHANNEL MODULATOR ON DIABETIC

CARDIOMYOPATHY IN RATSDR. TEJAL R. GANDHI

30 02-May-2019 172050825009 Vaibhav Hardikbhai Shah MRW403P 25 205 MP Pharmacology CVS DISORDER

PREPARATION AND EVALUATION OF POLYHERBAL

FORMULATION FOR THE TREATMENT OF DIABETIC

CARDIOMYOPATHY

DR. TEJAL R. GANDHI

31 25-April-2019 172060820002 MALAVIYA VIKASKUMAR MADHUBHAI MRW403P 20 206 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION DEVELOPMENT AND EVALUATION OF

ONDANSETRON HCL EXTENDED RELEASE TABLETDR. MITTAL MAHESHWARI

32 25-April-2019 172060820001 Gokani Preet Nitinkumar MRW403P 20 206 MP Pharmaceutics MISCELANEOUSFORMULATION DEVELOPMENT AND EVALUATION OF

ACECLOFENAC LOADED EMULGELDR. MITTAL MAHESHWARI

33 25-April-2019 172060820003 Swati Adhikari MRW403P 20 206 MP Pharmaceutics MISCELANEOUSIMPACT OF HOLD TIME ON PHYSICAL PARAMETERS OF

DRUG PRODUCTDR. MITTAL MAHESHWARI

34 25-April-2019 172060824001 CHAUHAN SUDIKSHA RAMKUMAR MRW403P 24 206 MPPharmaceutical


STABILITY INDICATING RP-UPLC METHOD DEVELOPEMENT

AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF

ASPIRIN, ROSUVASTATIN CALCIUM AND CLOPIDOGREL

DR. NEHA TIWARI

35 25-April-2019 172060824006 PATEL DIPALIBEN JAYANTIBHAI MRW403P 24 206 MPPharmaceutical


STABILITY INDICATING RP-UPLC METHOD DEVELOPEMENT

AND VALIDATION FOR OLMESARTAN MEDOXOMIL, DR. NEHA TIWARI

36 25-April-2019 172060824002 Dodiya Karan sinh Vajesangbhai MRW403P 24 206 MPPharmaceutical



RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DR. PRAGNESH PATANI

37 25-April-2019 172060824003 GUPTA MONIKA HARERAM MRW403P 24 206 MPPharmaceutical


DEVELOPEMENT AND VALIDATION OF STABILITY INDICATING

RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF

DOXOFYLLINE AND ACEBROPHYLLINE IN THEIR COMBINE

DOSAGE FORM

DR.PRAGNESH PATANI

38 25-April-2019 172060824004 MUDALIAR REVATI GANESHBHAI MRW403P 24 206 MPPharmaceutical



ASSAY RP-HPLC METHOD FOR THE SIMULTANEOUS

ESTIMATION OF DICYCLOMINE AND SIMETHICONE IN ITS

DR. PRAGNESH PATANI

39 25-April-2019 172060824012 VAGHELA YAVANTIKA VIRENDRASINH MRW403P 24 206 MPPharmaceutical



RP-HPLC METHOD FOR THE ESTIMATION OF DAPAGLIFLOZIN

IN ITS TABLET DOSAGE FORM

DR. PRAGNESH PATANI

40 25-April-2019 172060824005 PATEL BHARGAVKUMAR PRADIPBHAI MRW403P 24 206 MPPharmaceutical


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF

THE SIMULTANEOUS ESTIMATION OF

TRIHEXYPHENIDYL,TRIFLUOPERAZINE AND THIORIDAZINE IN

MRS.VANITA MARVANIYA

41 25-April-2019 172060824007 PATEL YASH KANUBHAI MRW403P 24 206 MPPharmaceutical

Quality AssuranceBIOANALYTICAL

BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION

FOR ESTIMATION OF FORMOTEROL IN HUMAN PLASMA BY

LC-MS/MS.

MRS.VANITA MARVANIYA

42 25-April-2019 172060824011 VAGHELA AKSHAY PRAVINBHAI MRW403P 24 206 MPPharmaceutical


STABILITY INDICATING HPLC METHOD DEVELOPMENT AND

VALIDATION FOR SIMULTANEOUS DETERMINATION OF DR. NEHA TIWARI

43 26-April-2019 172070820002 PANDYA KHYATIBEN NITINKUMAR MRW403P 20 207 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


“FORMULATION AND EVALUTION OF BILAYERED BUCCAL

TABLET OF IVABRADINE HYDROCHLORIDE”DR. VISHNU M. PATEL

44 26-April-2019 172070820003 patel yaminibahen nikhilkumar MRW403P 20 207 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


“FORMULATION AND EVALUTION OF BUCCAL PATCH

CONTAINING DULOXETINE HYDROCHLORIDE FOR THE DR. VISHNU M. PATEL

45 26-April-2019 172070820005 Vadaliwala Munavvarbanu Abdullatif MRW403P 20 207 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


DEVELOPMENT AND EVALUATION OF ORODISPERSIBLE

TABLET OF APIXABAN

DR. ANANDKUMAR

KANAIYALAL PATEL

46 26-April-2019 172070820001 MANSURI AKIBBHAI YASINBHAI MRW403P 20 207 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT AND CHARACTERIZATION OF CONTROLLED

RELEASE MATRIX TABLET OF TIAGABINE HYDROCHLORIDE

DR. ANANDKUMAR

KANAIYALAL PATEL

47 25-April-2019 172080820003 PATEL DHRUV JAYNESHKUMAR MRW403P 20 208 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF FIXED DOSE GASTRO-

RETENTIVE BILAYER TABLET CONTAINING METFORMIN AS

SUSTAINED RELEASE AND SIMVASTATIN AS IMMEDIATE

DR. UPENDRA L PATEL

48 25-April-2019 172080820001 BHATT VIBHUTI DHIRENKUMAR MRW403P 20 208 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST

DISPERSIBLE/DISSOLVISTUDY ON DISSOLUTION ENHANCEMENT OF EZETIMIBE DR. DASHRATH PATEL

49 25-April-2019 172080820002 DHRU KHUSHALI DARSHAKBHAI MRW403P 20 208 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF INTRANASAL DRUG

DELIVERY OF DIAZEPAM FOR STATUS EPILEPTICUS.DR. DASHRATH PATEL

50 25-April-2019 172080820004 RUPARELIYA KETA SHAILESHBHAI MRW403P 20 208 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


NASAL INSITU GEL OF ANTI-HIV DRUG FOR NOSE TO BRAIN

DRUG DELIVERY.DR. SUNITA CHAUDHARY

51 25-April-2019 172080824001 PANCHAL URVISHA GOVINDBHAI MRW403P 24 208 MPPharmaceutical


STABILITY INDICATING HPTLC METHOD DEVELOPMENT AND

VALIDATION OF DACLATASVIR DIHYDROCHLORIDE IN

PHARMACEUTICAL DOSAGE FORM

DR. RAGIN SHAH

52 25-April-2019 172080824004 PATEL NIDHIBEN VINODBHAI MRW403P 24 208 MPPharmaceutical


STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT

AND VALIDATION OF DOFETILIDE IN CAPSULE DOSAGE DR NISHA PARIKH

53 25-April-2019 172080824006 SHAH CHARMI RAJESH MRW403P 24 208 MPPharmaceutical



AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF

ILAPRAZOLE AND LEVOSULPRIDE IN PHARMACEUTICAL

MS JIGNASHA DERASARI

54 25-April-2019 172080824002 PARMAR MONIKA JAGDISHBHAI MRW403P 24 208 MPPharmaceutical



AND VALIDATION OF S(-) AMLODIPINE BESYLATE AND

HYDROCHLOROTHIAZIDE IN BULK AND PHARMACEUTICAL

MR HIREN KADIKAR

55 25-April-2019 172080824003 PATEL BHOOMIKA VINODBHAI MRW403P 24 208 MPPharmaceutical



AND VALIDATION OF DOLUTEGRAVIR, LAMIVUDINE AND

TENOFOVIR DISOPROXIL FUMARATE IN ITS COMBINED

MS MONA KAUSHAL

56 25-April-2019 172080824005 SAIYAD ANISH MIRSHABMIYA MRW403P 24 208 MPPharmaceutical


STABILITY INDICATING METHOD DEVELOPMENT AND

VALIDATION FOR SIMULTANEOUS ESTIMATION OF DR JITENDRA PATEL

57 30-April-2019 172120820002 BHATT UKTI JANAKBHAI MRW403P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

STUDIES IN APPLICATION OF HOT MELT EXTRUSION

TECHNIQUE FOR DEVELOPMENT OF DELAYED RELEASE DR S R SHAH

58 30-April-2019 172120820005 CHUDASAMA TARUN RAMESHBHAI MRW403P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF EXTENDED RELEASE

TABLET OF NIACIN.DR J R CHAVDA

59 30-April-2019 172120820006 GELHOR HIMANI BABUBHAI MRW403P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF SUSTAINED RELEASE

FLOATING TABLET OF CINNARIZINE.DR D R BHIMANI

60 30-April-2019 172120820003 BHOLA JAYDIPKUMAR HAJABHAI MRW403P 20 212 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


LIQUISOLID TABLET OF EFAVIRENZ FOR IMPROVING

DISSOLUTION CHARACTERISTICS: DESIGN, DEVELOPMENT

AND OPTIMIZATION

DR. M. M. SONIWALA

61 30-April-2019 172120820010 PATEL JETALBEN VASANTBHAI MRW403P 20 212 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


MEDICATED CHOCOLATE CONTAINING CEFIXIME

TRIHYDRATE: A NOVEL SOLID DOSAGE FORM FOR PEDIATRIC

PATIENTS.

K A PATEL

62 02-May-2019 172120825007 PATEL YASHIKAKUMARI ISHWARBHAI MRW403P 25 212 MP Pharmacology BABE STUDYBIOAVAILABILITY AND BIODISTRIBUTION STUDY OF

RIFAXIMIN CO-CRYSTALS IN RATSDR. RAVI A. MANEK

63 30-April-2019 172120820001 Bhanderi Brijesh Ashokbhai MRW403P 20 212 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DESIGN AND OPTIMIZATION OF LUTEIN LOADED SOLID LIPID

NANOPARTICLES FOR OPTHALMIC DELIVERYDR S R SHAH

64 30-April-2019 172120820004 CHRISTIAN PRAJAL MUKESHBHAI MRW403P 20 212 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND EVALUATION OF LAFUTIDINE

LIQUISOLID PELLETS FOR ENHANCEMENT OF DISSOLUTION .DR J S PAUN

65 02-May-2019 172120825004 MAHETAR NAFISA USMANBHAI MRW403P 25 212 MP PharmacologyRESPIRATORY DISORDER ( PLEASE

SPECIFY DISORDER OR

EVALUATION OF ETHANOLIC EXTRACT OF BOERHAAVIA

DIFFUSA L. LEAVES ON OVALBUMIN INDUCED ASTHMA

MODEL

DR. JIGNESH I. PATEL

66 02-May-2019 172120825008 VAGHASIYA TRUPTI PARSOTAMBHAI MRW403P 25 212 MP PharmacologyRESPIRATORY DISORDER ( PLEASE

SPECIFY DISORDER OR

EVALUATION OF EFFECT OF METHANOLIC EXTRACT OF

TERMINALIA CATAPPA L. IN EXPERIMENTAL ANIMAL MODEL

OF ASTHMA

DR. DEVANG B. SHETH

67 30-April-2019 172120820008 MAVANI CHINTAN PRAVINBHAI MRW403P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AT

DEVELOPMENT AND CHARACTERIZATION OF NOVEL CO-

PROCESSED EXCIPIENT OF TRICALCIUM CITRATE BY SPRAY

DRYING.

DR R D PARMAR

68 30-April-2019 172120820011 PRAJAPATI RAVIRAJ RAMESHKUMAR MRW403P 20 212 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN AND EVALUATION OF TRANSDERMAL PATCH

CONTAINING GRANISETRON HYDROCHLORIDEDR. J M PATEL

69 30-April-2019 172120820012 PRAJAPATI URVASHI RAMESHBHAI MRW403P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AT

PHYSICOCHEMICAL PROPERTY IMPROVEMENT OF

CEFPODOXIME PROXETIL BY CO PROCESSINGDR. JAYANT R. CHAVDA

70 30-April-2019 172120820013 SAKHIYA DHRUV CHANDRAKANTBHAI MRW403P 20 212 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


PREPARATION AND EVALUTION OF ITRACONAZOLE TOPICAL

NANOGELDR C H BORKHATARIYA

71 30-April-2019 172120820014 SANGHANI DIVYABEN VINODBHAI MRW403P 20 212 MP Pharmaceutics

CO PROCESSED, DC,


AT

AUGMENTATION OF PHYSICOCHEMICAL PROPERTIES OF

CEFUROXIME AXETIL BY SPHERICAL AGGLOMERATION.DR R D PARMAR

72 02-May-2019 172120825005 MATHUR ANMOL CHETENDRAKUMAR MRW403P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)

EVALUATION OF ANTI-ARTHRITIC POTENTIAL OF

METHANOLIC EXTRACT OF WHOLE PLANT OF BIOPHYTUM

SENSITIVUMIN FREUNDS ADJUVANT INDUCED ARTHRITIS IN

DR. JIGNESH I. PATEL

73 02-May-2019 172120825009 VAGHELA UJJVAL PARESHBHAI MRW403P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)

EFFECT OF ETHANOLIC EXTRACT OF PUERARIA TUBEROSA

(WILLD.)DC. TUBERS IN LETROZOLE INDUCED POLYCYSTIC

OVARIAN SYNDROME (PCOS) IN RATS

DR. DEVANG B. SHETH

74 30-April-2019 172120824001 Chavda Meghaben MRW403P 24 212 MPPharmaceutical

Quality AssuranceIMPURITY PROFILING


FOR ESTIMATION OF GENOTOXIC IMPURITIES IN DR. ASHOK B. PATEL

75 30-April-2019 172120824003 DHADUK AKTABEN RAMESHBHAI MRW403P 24 212 MPPharmaceutical

Quality AssuranceQUALITY RISK MANAGEMENT

QUALITY BY DESIGN APPROACH TO FIND DESIGN SPACE IN

THE DEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION MR. AJAY I. PATEL

76 30-April-2019 172120824002CHOUDHARY JYOTISHNA

BHOOPALSINGHMRW403P 24 212 MP

Pharmaceutical


ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR

THE ESTIMATION OF ARTEMETHER AND LUMEFANTRINE IN

MARKETED FORMULATION BY UPLC

DR. ASHOK B. PATEL

77 30-April-2019 172120824010 MODH JAIVIK HITESHKUMAR MRW403P 24 212 MPPharmaceutical



FOR ESTIMATION OF DICLOFENAC DIETHYLAMINE TOPICAL

SOLUTION BY RP-HPLC METHOD

DR. NILESH K. PATEL

78 30-April-2019 172120824012 PATEL KRUPALIBEN JAGADISHBHAI MRW403P 24 212 MPPharmaceutical


SIMULTANEOUS ESTIMATION OF DAPAGLIFLOZIN

PROPANEDIOL MONOHYDRATE & METFORMIN HCL IN BULK

AND TABLET DOSAGE FORM USING UPLC

DR.AMITKUMAR J .VYAS

79 30-April-2019 172120824013 PATEL RUPALBEN ASHOKBHAI MRW403P 24 212 MPPharmaceutical



ASSAY METHOD FOR SIMULTANEOUS ESTIMATION OF

AMLODIPINE BESYLATE AND CELECOXIB IN SYNTHETIC

DR. ASHOK B. PATEL

80 30-April-2019 172120824005 JANI SHIVANI NILESHKUMAR MRW403P 24 212 MPPharmaceutical

Quality AssuranceREGULATORY AFFAIRS

STUDY OF REGULATORY REQUIREMENTS FOR

PHARMACEUTICALS IN NON-EUROPEAN UNION MEMBER

STATES KOSOVO, UKRAINE AND SERBIA

DR. NILESH K. PATEL

81 30-April-2019 172120824006 JETHAVA PALAKBEN NANDLALBHAI MRW403P 24 212 MPPharmaceutical


EVALUATION OF INSTABILITY ISSUE IN PAEDIATRIC DRY

SYRUP OF CEPHALOSPORIN ANTIBIOTIC IN COMBINATION DR. NILESH K. PATEL

82 30-April-2019 172120824007 KATESHIYA GOVIND AMRUTLAL MRW403P 24 212 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF NAPROXEN AND

DIPHENHYDRAMINE IN K3EDTA HUMAN PLASMA BY USING MR. AJAY I. PATEL

83 30-April-2019 172120824008 KHATRI AKSHALIBEN RAMCHANDRA MRW403P 24 212 MPPharmaceutical



FOR ESTIMATION OF DOFETILIDE IN KȝEDTA HUMAN

PLASMA BY USING LC-ESI-MS/MS

MR. AJAY I. PATEL

84 30-April-2019 172120824009 KULKARNI POOJA CHANDRAKANT MRW403P 24 212 MPPharmaceutical



FOR ESTIMATION OF DOSULEPIN HYDROCHLORIDE IN

KʒEDTA HUMAN PLASMA BY USING LC-ESI-MS/MS


85 30-April-2019 172120824011 PARMAR ANKUR MOHANBHAI MRW403P 24 212 MPPharmaceutical



FOR ESTIMATION OF VARENICLINE TARTRATE USING KʒEDTA

HUMAN PLASMA BY LC-ESI-MS/MS

DR. ASHOK B. PATEL

86 30-April-2019 172120824015 SHARMA JIGNASHA KRUSHNAKANT MRW403P 24 212 MPPharmaceutical



FOR ESTIMATION OF FLUCYTOSINE IN KȝEDTA HUMAN



87 29-April-2019 172130820007 SHAH HARDIK SANJAYKUMAR MRW403P 20 213 MP PharmaceuticsVESICULAR DRUG DELIVERY

SYSTEM

DEPOFOAM TECHNOLOGY BASED INTRAMUSCULAR DRUG

DELIVERY OF PREDNISOLONE ACETATE FOR TREATMENT OF DR.PRACHI PANDEY

88 29-April-2019 172130820004 PATEL DHRUVI KAMLESHBHAI MRW403P 20 213 MP Pharmaceutics

CO PROCESSED, DC,


AT

PREPARATION AND CHARACTERIZATION OF SPRAY DRIED

SOLID DISPERSION OF AN ANTI-DIABETIC DRUG FOR

DISSOLUTION ENHANCEMENT

DR. NAAZNEEN SURTI

89 02-May-2019 172130825004 NEMADE MRUNALI ASHOK MRW403P 25 213 MP Pharmacology BABE STUDYCOGNITION ASSESSMENT AMONG INDIAN PATIENTS WITH

HEAD AND NECK CANCER USING PROMIS AND ICCTF DR. DEEPTI K. JANI

90 02-May-2019 172130825005 PANDEY RASHI SURESHKUMAR MRW403P 25 213 MP Pharmacology BABE STUDY

BIOEQUIVALENCE STUDY OF FESOTERODINE FUMARATE

PROLONGED RELEASE TABLETS 8 MG IN FASTING

CONDITIONS

DR. DIGVIJAYSINH G. RANA

91 02-May-2019 172130825006 PARMAR MOHINI DHARMENDRASINH MRW403P 25 213 MP Pharmacology BABE STUDYBIOEQUIVALENCE STUDY OF FESOTERODINE FUMARATE

PROLONGED RELEASE TABLETS 8 MG IN FED CONDITIONSDR. DEEPTI K. JANI

92 29-April-2019 172130820001 KM SHALINI SHARMA MRW403P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY)CYCLODEXTRIN BASED NANOSPONGES: AN EFFECTIVE

METHOD FOR DISSOLUTION ENHANCEMENT OF LOW DR ASHOK MAHAJAN

93 29-April-2019 172130820002 MISTRY JHEEL RAJUBHAI MRW403P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF NANOEMULSION

BASED IN-SITU GEL FOR OCULAR DRUG DELIVERY OF

ACECLOFENAC

DR.PRIYAL PATEL

94 29-April-2019 172130820005 PATEL VAISHNAVIBEN PRAVINBHAI MRW403P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY)VAGINAL DRUG DELIVERY SYSTEM OF METHOTREXATE FOR

TREATMENT OF RHEUMATOID ARTHRITISDR. NAAZNEEN SURTI

95 29-April-2019 172130820008 TELI ANJALIBEN KUSHALCHANDRA MRW403P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT OF TARGETED FORMULATION OF

BUDESONIDE FOR INFLAMMATORY BOWEL DISEASE DR. MANISHA S. LALAN

96 29-April-2019 172130820009 TRIVEDI RUSHI JAWAHARLAL MRW403P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF INTRANASAL IN-SITU

GEL OF PRAMIPEXOLE DIHYDROCHLORIDEDR.MEENAKSHI PATEL

97 29-April-2019 172130820003 NAZIYA ILYAS GHEEWALA MRW403P 20 213 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


SPRAY DRIED SOLID DISPERSION : AN EFFICIENT METHOD

FOR DISSOLUTION ENHANCEMENT OF NEVIRAPINEDR ASHOK MAHAJAN

98 29-April-2019 172130820006 PATEL VRUNDA SANJAYKUMAR MRW403P 20 213 MP Pharmaceutics MISCELANEOUS

PREPARATION AND EVALUATION OF DRY POWDER INHALER

FORMULATION FOR PULMONARY DELIVERY OF

CEFTAZIDIME.

DR.PRIYAL PATEL

99 02-May-2019 172130825002 MAYUR WANKHADE MRW403P 25 213 MP Pharmacology OTHER (KINDLY SPECIFY)NUTRACEUTICAL INTERVENTIONS IN PACLITAXEL- INDUCED

NEUROPATHIC PAIN: AN EXPERIMENTAL STUDYDR. DEEPTI K. JANI

100 29-April-2019 172130824008 UPADHYAY KHYATIBEN VIJAYKUMAR MRW403P 24 213 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF LIQUID

CHROMATOGRAPHIC METHOD FOR ESTIMATION OF

FIMASARTAN POTASSIUM TRIHYDRATE IN PRESENCE OF ITS

DR. DIMAL SHAH

101 29-April-2019 172130824001 JOSHI KRUPABEN PRAVINBHAI MRW403P 24 213 MPPharmaceutical



FOR THE ESTIMATION OF FLIBANSERIN IN THE PRESENCE OF

ITS RELATED SUBSTANCE

DR. FALGUN A. MEHTA

102 29-April-2019 172130824003 NAIR SHREYA RADHAKRISHNAN MRW403P 24 213 MPPharmaceutical



FOR THE ESTIMATION OF POLMACOXIB IN PRESENCE OF ITS DR. FALGUN A. MEHTA

103 29-April-2019 172130824004 PANCHAL PRACHI VISHNUKUMAR MRW403P 24 213 MPPharmaceutical



FOR THE ESTIMATION OF NETUPITANT IN THE PRESENCE OF

ITS RELATED SUBSTANCE

DR. FARHATJAHAN SHAIKH

104 02-May-2019 172130825001 KUNDU SMITA SUMANKUMAR MRW403P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF LOXOPROFEN IN VARIOUS

ANIMAL MODELS OF DEPRESSIONDR. DIGVIJAYSINH G. RANA

105 02-May-2019 172130825003 Mitra Pratik Sapan MRW403P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF TERIFLUNOMIDE IN VARIOUS


106 02-May-2019 172130825007 PATEL RUTU MANOJKUMAR MRW403P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF MONTELUKAST IN VARIOUS


107 29-April-2019 172130824002MIRZA NILAMFATEMA

MOHAMMADASKARIMRW403P 24 213 MP

Pharmaceutical



FOR SIMULTANEOUS ESTIMATION OF PITAVASTATIN

CALCIUM AND EZETIMIBE FROM ITS COMBINED TABLET

DR. VANDANA B. PATEL

108 29-April-2019 172130824005 PARMAR PAYAL MAHESHBHAI MRW403P 24 213 MPPharmaceutical



FOR ESTIMATION OF VALBENAZINE TOSYLATE IN BULKDR. VANDANA B. PATEL

109 29-April-2019 172130824006 PRAJAPATI DHRUVI ANILKUMAR MRW403P 24 213 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR

ANALYSIS OF ALOGLIPTIN BENZOATE IN THE PRESENCE OF

ITS RELATED SUBSTANCES

DR. SHAILESH KORADIA

110 29-April-2019 172130824007 TAHILRAMANI POOJA JAGDISH MRW403P 24 213 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF UV AND

CHROMATOGRAPHIC METHODS FOR ESTIMATION OF

MIRABEGRON AND SOLIFENACIN SUCCINATE IN

DR. DIMAL SHAH

111 01-May-2019 172150820001 HITESH SANJAY BAKAS MRW403P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND DEVELOPMENT OF RAFT FORMING

FLOATING DRUG DELIVERY SYSTEM FOR DOMPERIDONE

SUSTAIN DRUG RELEASE

MR VINOD RAMANI

112 01-May-2019 172150820002 PARMAR HIRENKUMAR NARANBHAI MRW403P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

To Study the effect of hydro-alcoholic media on drug release

behavior of extended release tablet containing metoprololMR VINOD RAMANI

113 01-May-2019 172150820004 YADAV AJAY CHHOTELAL MRW403P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND DEVELOPMENT OF IN SITU GEL

CONTAINING LEVOFLOXACIN LOADED LIPOSOME FOR

PERIODONTITIS

MR. R. SENTHIL KUMAR

114 01-May-2019 172150824002 GUPTA VANDANA BARJENDRA MRW403P 24 215 MPPharmaceutical



FLUPIRTINE MALEATE AND TRAMADOL HYDROCHLORIDE IN

SYNTHETIC MIXTURE

DR. ZARNA DEDANIA

115 01-May-2019 172150824003 KERIWALA TEJAL MANOJKUMAR MRW403P 24 215 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC

AND HPLC METHODS FOR LULICONAZOLE AND

DR. GHANSHYAM

SHANGHANI

116 01-May-2019 172150824005 SHAH ABHISHEKKUMAR BHARATKUMAR MRW403P 24 215 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC

AND HPLC METHODS FOR ZONISAMIDE AND CILOSTAZOL IN DR. ZARNA DEDANIA

117 01-May-2019 172150824004 PRAJAPATI RICHA ATULBHAI MRW403P 24 215 MPPharmaceutical


QBD APPROACH TO HPLC METHOD DEVELOPMENT AND

VALIDATION FOR THE ESTIMATION OF FLUOXETINE

HYDROCHLORIDE AND OLANZAPINE IN PHARMACEUTICAL

DR. ZARNA DEDANIA

118 01-May-2019 172150824001 CHISTI ZENAB MOHD MASOOD MRW403P 24 215 MPPharmaceutical


HPTLC method development and validation of Naproxen

Sodium and Esomeprazole Magnesium Trihydrate in DR. ZARNA DEDANIA

119 29-April-2019 172150827001 BHANDARI KRISHNA KAUSHIKKUMAR MRW403P 27 215 MPPharmaceutical

Regulatory AffairsREGULATORY AFFAIRS

CURRENT REGULATORY REQUIREMENT FOR EXPORT OF

SOLID ORAL DOSAGE FORM IN BRAZIL AND MEXICODR .VINEET JAIN

120 29-April-2019 172150827002 Chaudhary Reena Bhagawanswaroop MRW403P 27 215 MPPharmaceutical


GUIDELINES AND REGULATORY REQUIREMENTS FOR

LABELLING AND PACKAGING OF INJECTIONS IN USA,

EUROPE, INDIA AND CANADA.

DR. RONAK DEDANIA

121 29-April-2019 172150827003 Dobariya Janki Rasikkumar MRW403P 27 215 MPPharmaceutical

Regulatory AffairsSIMULTENEOUS ESTIMATION

A COMPREHENSIVE STUDY ON REGULATORY

REQUIREMENTS FOR PRODUCT REGISTRATION OF VACCINES

IN USA, EUROPE AND CANADA.

DR. RONAK DEDANIA

122 29-April-2019 172150827004 Juneja Parul jitender MRW403P 27 215 MPPharmaceutical


REGULATORY GUIDELINES OF HAZARD ANALYSIS CRITICAL

CONTROL POINT (HACCP) WITH COMPREHENSIVE STUDY ON

STANDARDS AND CERTIFICATION PROCEDURES IN USA,

DR. RONAK DEDANIA

123 29-April-2019 172150827005 MAHLA SWETA MAVJIBHAI MRW403P 27 215 MPPharmaceutical


A COMPARATIVE STUDY OF REGULATORY REQUIREMENTS

AND GUIDELINES FOR MEDICAL DEVICES IN USA,JAPAN AND DR. RONAK DEDANIA

124 29-April-2019 172150827008 TAILOR BRINDA ASHISHKUMAR MRW403P 27 215 MPPharmaceutical


CURRENT STATUS OF GENERIC DRUG APPROVAL PROCESS IN

UNITED STATES OF AMERICA AND EUROPEAN UNIONDR .VINEET JAIN

125 29-April-2019 172150827009YADAV KUSUM KUMARI SHREE DINESH

KUMARMRW403P 27 215 MP

Pharmaceutical


NAVIGATING REGULATORY FRAMEWORK TO DEFEAT ZIKA

VIRUS IN USA AND EUDR .VINEET JAIN

126 29-April-2019 172230828002 KAPADIA DHWANI PREYAS MRW403P 28 223 MPPharmaceutical

Technology

BUCO/MUCOADHESIVE, TDDS,


FORMULATION AND CHARACTERIZATION OF LIPOSOME

BASED INTRA-NASAL DELIVERY OF ARIPIPRAZOLE

DR. ALIASGAR J

KUNDAWALA

127 29-April-2019 172230828001 DESAI ANJALI DATTATRAY MRW403P 28 223 MPPharmaceutical

TechnologyOTHER (KINDLY SPECIFY)

DEVELOPMENT AND EVALUATION OF SPRAY DRIED

INHALABLE DRY POWDER OF POSACONAZOLE FOR

DR. ALIASGAR J

KUNDAWALA

128 29-April-2019 172230823002 Patel Keshaben Manojbhai MRW403P 23 223 MPPharmaceutical

AnalysisOTHER (KINDLY SPECIFY)


FOR THE QUANTIFICATION OF MACITENTAN IN BULK AND


DR. USMANGANI K.

CHHALOTIYA

129 29-April-2019 172230823003 YADAV PREETIBEN NARESHKUMAR MRW403P 23 223 MPPharmaceutical

AnalysisOTHER (KINDLY SPECIFY)

DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC

AND UV-VISIBLE SPECTROSCOPIC METHODS FOR

QUANTIFICATION OF MIRABEGRON IN BULK AND

DR. USMANGANI K.

CHHALOTIYA

130 25-April-2019 172240824001 CHAUDHARY RAJESHBHAI BHIKHABHAI MRW403P 24 224 MPPharmaceutical



VALIDATION FOR SIMULTANEOUS ESTIMATION OF DR. HIRAL PANCHAL

131 25-April-2019 172240824002 DAMSIYA NIKHIL KARSHANBHAI MRW403P 24 224 MPPharmaceutical



VALIDATION FOR SIMULTANEOUS ESTIMATION OF DR. HIRAL PANCHAL

132 26-April-2019 172250820003 Patel Bhaveshkumar Amrutlal MRW403P 20 225 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF BUCCAL FILMS OF

PIRIBEDILDR. SHAILESH T. PRAJAPATI

133 26-April-2019 172250820006 PATEL RAJAT BHARATBHAI MRW403P 20 225 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND EVALUATION OF SUSTAINED RELEASE

MICROSPHERES OF ITOPRIDE HYDROCHLORIDE DR. KEYUR S. PATEL

134 26-April-2019 172250820008 PATEL VRUNDABEN CHHGANBHAI MRW403P 20 225 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF SUBLINGUAL FILM OF

IVABRADINE HYDROCHLORIDEDR. KEYUR S. PATEL

135 26-April-2019 172250820002 KANSAGARA AMEEBEN RAMNIKBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF COLON TARGETED

TABLETS OF ELUXADOLINEDR. SHAILESH T. PRAJAPATI

136 26-April-2019 172250820004 PATEL JASMINABAHEN VISHNUBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


MATRIX TABLETS OF NATEGLINIDEDR. SHAILESH T. PRAJAPATI

137 26-April-2019 172250820005 PATEL NILESHKUMAR MUKESHBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF GASTRORETENTIVE

MUCOADHESIVE TABLETS OF RANOLAZINEDR. KEYUR S. PATEL

138 26-April-2019 172250820007 PATEL SUMIT RAJESHBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF FLOATING TABLETS OF

PROPAFENONE HYDROCHLORIDEDR. KEYUR S. PATEL

139 26-April-2019 172250824002 HIRAPARA FENIBEN JAYANTILAL MRW403P 24 225 MPPharmaceutical



VALIDATION OF AMOXYCILLIN AND CLAVULANIC ACID IN Dr. SAMIR C. PATEL

140 26-April-2019 172250824004 KACHCHHI RIDDHI RAMESHBHAI MRW403P 24 225 MPPharmaceutical


STABILITY INDICATING CHROMATOGRAPHIC METHOD

DEVELOPMENT AND VALIDATION OF SERTACONAZOLE

NITRATE AND ZINC PYRITHIONE IN SHAMPOO

DR. DEEPA R. PATEL

141 26-April-2019 172250824006 PATEL LAVINA GHANSHYAMBHAI MRW403P 24 225 MPPharmaceutical



DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS DR. DEEPA R. PATEL

142 26-April-2019 172250824007 PATEL PINKI RANCHHODBHAI MRW403P 24 225 MPPharmaceutical



DEVELOPMENT AND VALIDATION OF ENROFLOXACIN AND

BROMHEXINE HCI IN COMBINED DOSAGE FORM

DR. DEEPA R. PATEL

143 26-April-2019 172250824008 SK MOTIUR RAHAMAN MRW403P 24 225 MPPharmaceutical



DEVELOPMENT AND VALIDATION OF BETAHISTINE

DIHYDROCHLORIDE AND DOMPERIDONE IN COMBINED

Dr. SAMIR C. PATEL

144 26-April-2019 172250824009 VYAS RAMA SHIVKUMAR MRW403P 24 225 MPPharmaceutical


STABILITY INDICATING HPLC METHOD FOR STIMULTANEOUS

ESTIMATION OF SERTACONAZOLE AND BECLOMETHASONE

IN THEIR COMBINED DOSAGE FORM

DR. DEEPA R. PATEL

145 26-April-2019 172250824001 Dhruv Nikita Mahendrakumar MRW403P 24 225 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR

SIMULTANEOUS ESTIMATION OF BENIDIPINE HCL,

TELMISARTAN AND CHLORTHALIDONE IN TABLET DOSAGE

FORM

DR. DEEPA R. PATEL

146 26-April-2019 172250824005 PANCHAL HINABEN HASUBHAI MRW403P 24 225 MPPharmaceutical


METHOD DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF TRIHEXYPHENIDYL,

THIORIDAZINE AND TRIFLUOPERAZINE IN ITS

PHARMACEUTICAL DOSAGE FORM BY HPLC

DR. DEEPA R. PATEL

147 26-April-2019 172250824003 JAIN JUHI ANILKUMAR MRW403P 24 225 MPPharmaceutical



DEVELOPMENT AND VALIDATION OF BENIDIPINE

HYDROCHLORIDE AND CHLORTHALIDONE IN TABLET

DR. DEEPA R. PATEL

148 25-April-2019 172280820001 BHAVSAR JAINI PANKAJKUMAR MRW403P 20 228 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION, DEVELOPMENT AND EVALUATION OF

CONTROLLED RELEASE TABLET OF TENELIGLIPTIN

HYDROBROMIDE HYDRATE

DR. YAMINI SHAH

149 25-April-2019 172280820009 Shah Pahini Jigarbhai MRW403P 20 228 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION, OPTIMIZATION AND EVALUATION OF

CONTROLLED RELEASE TABLETS OF LORCASERIN

HYDROCHLORIDE

DR. MANISH P. PATEL

150 25-April-2019 172280820005 NAMIT GUPTA MRW403P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


MOUTH DISSOLVING FILMS OF NARATRIPTAN

HYDROCHLORIDEDR. MANISH P. PATEL

151 25-April-2019 172280820007 Patel Het Suryakantbhai MRW403P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION, DEVELOPMENT AND EVALUATION OF ORAL

DOSAGE FORM OF RISEDRONATE SODIUMDR. PRAFUL BHARADIA

152 25-April-2019 172280820003 JAHNAVI BHARGAV JANI MRW403P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



TOPICAL PREPARATION OF LUTEIN DR. PRAFUL BHARADIA

153 25-April-2019 172280820004 MANAN VISHNUBHAI PATEL MRW403P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND DEVELOPMENT OF ORAL

TRANSMUCOSAL DELIVERY SYSTEM OF AN ANTI-MIGRAINE

AGENT

DR. RADHIKA PANDYA

154 25-April-2019 172280820006 PATEL GRUSHA SANJAYKUMAR MRW403P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



SPIRONOLECTONE GEL FOR TREATMENT OF ANDROGENIC

ALOPECIA

DR. PRAFUL BHARADIA

155 25-April-2019 172280820002 DESHMUKH GAURI NITEEN MRW403P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION, DEVELOPMENT AND EVALUATION OF SOLID

ORAL DOSAGE FORM OF PAROXETINE HYDROCHLORIDEDR. PRAFUL BHARADIA

156 25-April-2019 172280820008 ROMANSHA ANIL BERI MRW403P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



SUBLINGUAL TABLETS OF AN ANTI-PSYCHOTIC DRUGDR. YAMINI SHAH

157 25-April-2019 172280820010 SOLANKI SNEHABEN BALDEVBHAI MRW403P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY)PAEDIATRIC FORMULATION OF CEFIXIME TRIHYDRATE AND

ITS EVALUATIONDR. YAMINI SHAH

158 02-May-2019 172280825002 DOBARIYA KOMAL MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATE THE THERAPEUTIC POTENTIAL OF CHRYSIN IN

TYPE -2 DIABETES AND ITS COMPLICATIONSDR. ANITA A MEHTA

159 02-May-2019 172280825003 GORAKHIYA MONIKA SHAILESHBHAI MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

ASSESSMENT OF INSULIN EFFECT IN HYPOTHYROIDISM AND

OBESITY IN RATS

DR. MUSTAKIM M.

MANSURI

160 02-May-2019 172280825004 JAINEEL RAJESHBHAI DHAROD MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF ANTI-OBESITY EFFECT OF BUPROPION AND

L-HISTIDINE COMBINATION IN HFD INDUCED OBESITY IN

MICE

DR. GAURANG B. SHAH

161 02-May-2019 172280825009 YADAV RUCHIBEN SHITALAPRASAD MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EFFECT OF GENISTEIN ON OVARIAN FUNCTION IN

HYPOTHYRODISED RAT

DR. MUSTAKIM M.

MANSURI

162 25-April-2019 172280824004 MODI PINAL SATISHKUMAR MRW403P 24 228 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF NEBIVOLOL

HYDROCHLORIDE AND TELMISARTAN IN THEIR COMBINED

DR. SINDHU EZHAVA

163 02-May-2019 172280825006 PURAV SUNILBHAI PATEL MRW403P 25 228 MP Pharmacology CVS DISORDEREVALUATE THE EFFECT OF TLR-4 ANTAGONIST IN

EXPERIMENTAL MODEL OF MYOCARDIAL INFARCTIONDR. ANITA A MEHTA

164 25-April-2019 172280824005 Patel Nidhi Tikendrabhai MRW403P 24 228 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC

METHOD FOR SIMULTANEOUS ESTIMATION OF OFLOXACIN,

TINIDAZOLE, TERBINAFINE HYDROCHLORIDE AND

CLOBETASOL PROPIONATE IN TOPICAL FORMULATION

DR. KUNJAN BODIWALA

165 25-April-2019 172280824008 SHARMA PRIYANKA KAMLESHBHAI MRW403P 24 228 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF A STABILITY

INDICATING HPTLC METHOD FOR TENELIGLIPTIN AND

METFORMIN.

DR. MAHESH T. CHHABRIA

166 02-May-2019 172280825001 BHOOMIT MAHENDRABHAI PATEL MRW403P 25 228 MP Pharmacology CANCEREFFECT OF DISULFIRAM AND CAFFEINE ON NSCLC

RESISTANCE TO GEMCITABINE AND CISPLATINDR. SUNITA GOSWAMI

167 02-May-2019 172280825007 Sangtani Kajol Haresh MRW403P 25 228 MP Pharmacology CNS DISORDER

ASSESSMENT OF THE RELATIONSHIP BETWEEN

ANTIDEPRESSANT AND COGNITION IMPROVING ABILITIES

OF SHANKHPUSHPI AND ASHWAGANDHA EXTRACTS IN MICE

DR. SUNITA GOSWAMI

168 02-May-2019 172280825008 Suthar Hiran Nilesh MRW403P 25 228 MP Pharmacology CNS DISORDER

EVALUATION OF WITHANIA SOMNIFERA AND

CONVULVULUS PLURICAULIS (CHOISY) ON VARIOUS

DOMAINS OF COGNITION IMPAIRED IN SUB-CHRONIC

KETAMINE INDUCED SCHIZOPHRENIA IN RATS

DR. GAURANG B. SHAH

169 26-April-2019 172280824003 HAPPY PARIN PATEL MRW403P 24 228 MPPharmaceutical



CHROMATOGRAPHIC METHOD FOR ESTIMATION OF

ALFUZOSIN HYDROCHLORIDE AND SOLIFENACIN SUCCINATE

IN THEIR COMBINED DOSAGE FORM

DR. SINDHU EZHAVA

170 26-April-2019 172280824006 Shah Jaldhi Hemantbhai MRW403P 24 228 MPPharmaceutical



METHOD FOR ESTIMATION OF DAPAGLIFLOZIN AND ITS

APPLICATION TO STUDY DEGRADATION KINETICS

DR. KUNJAN BODIWALA

171 30-April-2019 172310820001 Balas Mayur Vashrambhai MRW403P 20 231 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND EVALUATION OF NIOSOMAL GEL OF

VORICONAZOLE FOR SEVERE FUNGAL INFECTIONDR. SANDIP PATEL

172 30-April-2019 172310820002 Garachar Dhaval Ranabhai MRW403P 20 231 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND CHARACTERIZATION OF ACARBOSE

OSMOTIC TABLETSMR. SUMIT CHAKRABORTY

173 30-April-2019 172310820003 KALARIA VISHWA JITENDRABHAI MRW403P 20 231 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN AND EVALUATION OF INSITU GEL EYE DROPS

CONTAINING NANOPARTICLES OF GEMIFLOXACIN MESYLATEMR. SUMIT CHAKRABORTY

174 29-April-2019 172350820001 Bariya Hiralbhai Ranchhodbhai MRW403P 20 235 MP Pharmaceutics

CO PROCESSED, DC,


AT

FORMULATION DEVELOPMENT AND CHARACTERIZATION OF

DIRECTLY COMPRESSIBLE TABLETS OF NISOLDIPINE LOADED

SPHERICAL CRYSTAL AGGLOMERATES

DR. HITESH JAIN

175 29-April-2019 172350820002 Dindod Swetalben Babubhai MRW403P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN AND CHARACTERIZATION OF MICROSPONGE

LOADED TOPICAL GEL OF LULICONAZOLEDR. HITESH JAIN

176 29-April-2019 172350820003 NEHATE SHWETA BHAGWAN MRW403P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION DEVELOPMENT AND OPTIMIZATION OF

MUCOADHESIVE IN SITU NASAL GEL CONTAINING

MONTELUKAST SODIUM

DR. HITESH JAIN

177 01-May-2019 172390820004 CHIRAG NATUBHAI PATEL MRW403P 20 239 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN AND CHARACTERIZATION OF TRANSDERMAL PATCH

OF VENLAFAXINE HYDROCHLORIDEDR. HITESH DALVADI

178 01-May-2019 172390820009 Patel Kinjal Ishwarbhai MRW403P 20 239 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


DESIGN & OPTIMIZATION OF INTRANASAL DRUG

DELIVERY(SPRAY) OF QUETIAPINE FUMARATEDR. HITESH DALVADI

179 01-May-2019 172390820010 SIDDIKI DOLLY SAFIULREHMAN MRW403P 20 239 MP Pharmaceutics FORMULATION, EVALUATION AND OPTIMIZATION OF

MICROEMULSION BASED HYDROGEL OF TOLNAFTATEDR. HITESH DALVADI

180 01-May-2019 172390820002 BHANDARI RINAL HASMUKHRAI MRW403P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION, EVALUATION AND OPTIMIZATION OF IN-

SITU NASAL GEL OF FROVATRIPTAN SUCCINATEMR. TULARAM BAROT

181 01-May-2019 172390820005 HALPATI DARSHITA UMESH MRW403P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT AND EVALUATION OF NANOPARTICLE BASED

IN-SITU GEL OF LOTEPREDNOL ETABONATEDR. HITESH DALVADI

182 01-May-2019 172390820012 SINGH SHOBHA DESHRAJ MRW403P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND DEVELOPMENT OF IN-SITU GEL FOR

OCULAR DRUG DELIVERY OF TRAVOPROSTDR. KOMAL PARMAR

183 01-May-2019 172390820001 BEHERA SHREEKANT SHIVRAM MRW403P 20 239 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION AND DEVELOPMENT OF POLYMERIC MICELLE

FOR DISSOLUTION ENHANCEMENT OF EXEMESTANEDR. KOMAL PARMAR

184 01-May-2019 172390820003 CHAUHAN VRUTTIKUMARI BANKIMSINH MRW403P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DEVELOPMENT, EVALUATION AND OPTIMIZATION OF

OXICONAZOLE NITRATE LOADED SOLID LIPID NANOPARTICLE

BASED GEL

MR. TULARAM BAROT

185 01-May-2019 172390820006 OZA KIRTIBAHEN MANISHKUMAR MRW403P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION, EVALUATION AND OPTIMIZATION OF

NANOSUSPENSION FOR DISSOLUTION ENHANCEMENT OF

ZOTEPINE

DR. KOMAL PARMAR

186 01-May-2019 172390820008 PATEL JIGNESHBHAI UTTAMBHAI MRW403P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND DEVELOPMENT OF NOVEL BIGEL

TOPICAL DRUG DELIVERY OF LULICONAZOLEDR. KOMAL PARMAR

187 02-May-2019 172390825001 RAJAWAT MAYANK PRAFUL MRW403P 25 239 MP PharmacologyRESPIRATORY DISORDER ( PLEASE

SPECIFY DISORDER OR

PHARMACOLOGICAL SCREENING OF FOUR PROPIETARY

POLYHERBAL FORMULATION FOR THE TREATMENT OF MR. MITTAL DALAL

188 02-May-2019 172390825004 TANDEL SHIVANI RAJESHBHAI MRW403P 25 239 MP Pharmacology EYE DISORDEREFFECT OF ISOTINE®, ISOTINE PLUS® AND ISOTINE GOLD® IN

EXPERIMENTAL MODELS OF CATARACT AND GLAUCOMA.DR. ARINDAM PAUL

189 01-May-2019 172390824001 BHANUSHALI PRIYA DEVJIBHAI MRW403P 24 239 MPPharmaceutical


SPECTROSCOPIC AND CHROMATOGRAPHIC METHODS

DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF DR. ALISHA PATEL

190 01-May-2019 172390824002 KAMLI ANKITA SHANTILAL MRW403P 24 239 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF CANDESARTAN MADHURI HINGE

191 01-May-2019 172390824003 KUMBHAR RIDDHI SHIVAJI MRW403P 24 239 MPPharmaceutical


ANALYTICAL METHODS DEVELOPMENT AND VALIDATION

FOR AMLODIPINE BESYLATE AND CELECOXIB AND

EVALUATION OF AN ACTIVATED CARBON BASED

DR. ALISHA PATEL

192 02-May-2019 172390825003 SHAIKH UMAIRA ABDULRAKIB MRW403P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY)ANTICOAGULANT AND ANTIHEMOLYTIC ACTIVITY OF

TECOMELLA UNDULATA -AN EXPERIMENTAL STUDYDR. ANKIT H MERAI

193 01-May-2019 172390824005 PATEL HETA AMRUTBHAI MRW403P 24 239 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF AMITRIPTYLINE

MRS. MEGHA ASHESH

SHAH

194 01-May-2019 172390824004 Madhumita Ghosh Chowdhury MRW403P 24 239 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF ANALYTICAL

METHODS FOR ESTIMATION OF LIFITEGRAST IN ITS


MADHURI HINGE

195 25-April-2019 172420820002 Parekh Aarti Jayprakash MRW403P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT & EVALUATION OF GASTRO RETENTIVE

FLOATING TABLETS FOR ORAL DRUG DELIVERY OF

ENTACOPONE

DR DHAVAL J PATEL

196 25-April-2019 172420820004 Patel Parth Laxmanbhai MRW403P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF GASTRIC FLOATING

TABLETS CONTAINING CAPTOPRIL AND

HYDROCHLOROTHIAZIDE

DR S.K.SHAH

197 25-April-2019 172420820005 PATEL PRIYANK MUKESHBHAI MRW403P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND IN-VITRO DISSOLUTION ENHANCEMENT

OF BLONANSERIN USING LIQUISOLID COMPACTSDR SANJESH G RATHI

198 25-April-2019 172420820007 SHAH JIGAR PRADIPKUMAR MRW403P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


FLOATING TABLETS OF APREMILASTDR DHAVAL J.PATEL

199 25-April-2019 172420820001 GOSWAMI ASAV NARENDRAPURI MRW403P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


PHYSICOCHEMICAL CHARACTERIZATION AND IN-VITRO

DISSOLUTION ENHANCEMENT OF RANOLAZINE USING SOLID

DISPERSION METHOD

DR S.K.SHAH

200 25-April-2019 172420824003 MANGROLIYA RUCHITA HIMMATBHAI MRW403P 24 242 MPPharmaceutical

Quality AssurancePROCESS VALIDATION

PROSPECTIVE PROCESS VALIDATION OF

ANTIINFLAMMATORY (CORTICOSTEROID) INJECTION

SUSPENSION USP 40 MG/ML

DR. ANKIT B. CHAUDHARY

201 25-April-2019 172420824005 SUDHIRKUMAR GAMI MRW403P 24 242 MPPharmaceutical


RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF BENIDIPINE

HYDROCHLORIDE, TELMISARTAN AND CHLORTHALIDONE IN

TABLET


202 25-April-2019 172420824006 SUTHAR NISHABEN JAYESHKUMAR MRW403P 24 242 MPPharmaceutical



AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF

ORLISTAT AND RESVERATROL IN CAPSULE

MS. CHARMY D. PANDYA

203 26-April-2019 172420824001 BAGHEL LAXMI SHIVNARAYANSINGH MRW403P 24 242 MPPharmaceutical


DOCUMENTATION IN QUALITY MANAGEMENT SYSTEM

(QMS) AND DATA INTEGRITY IN PHARMACEUTICAL

INDUSTRY

MS. JIGNA T. PATEL

204 26-April-2019 172420824004 PATEL MINALBEN VINODBHAI MRW403P 24 242 MPPharmaceutical


A COMPREHENSIVE AND COMPARATIVE STUDY ON

REGULATIONS OF MEDICAL COUNTERMEASURES IN USA,

EUROPE AND INDIA


205 29-April-2019 172440820003 PATEL RIKIN RAMESH MRW403P 20 244 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION, DEVELOPMENT AND EVALUATION OF

MEDICATED CHEWING GUM OF AVANAFILM. RAHIL G. BHURA

206 02-May-2019 172450829001 Chaudhary Rajat b MRW403P 29 245 MP Clinical Pharmacy BABE STUDY

A RANDOMIZED DOUBLE BLINDED, CROSS-OVER

BIOEQUIVALENCE STUDY OF FELODIPINE EXTENDED RELEASE

(10 MG) TABLET UNDER FASTING CONDITION

DR. I. S. ANAND

207 02-May-2019 172450829002 Chaudhary Shefali Jayantibhai MRW403P 29 245 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)STUDY ON PRESCRIBING PATTERN OF ANTIBIOTICS IN

PATIENTS ADMITTED TO INTENSIVE CARE UNITSDR. I. S. ANAND

208 02-May-2019 172450829003 Chaudhary Sumanben Rameshbhai MRW403P 29 245 MP Clinical Pharmacy BABE STUDY

A RANDOMIZED CROSS-OVER BIOEQUIVALENCE STUDY OF

METOPROLOL SUCCINATE EXTENDED RELEASE (200 MG)

TABLET UNDER FASTING CONDITION

DR. I. S. ANAND

209 26-April-2019 172450820001 Chaudhary Jigneshkumar Ishwarbhai MRW403P 20 245 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND OPTIMIZATION OF ORODISPERSIBLE

TABLET OF A SELECTIVE ALPHA ADRENERGIC BLOCKING

AGENT USING NEFTOPIDIL

DR. H.D.KAREN

210 26-April-2019 172450820002 Vaghela Harshkumar Chamanlal MRW403P 20 245 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

PREPARATION AND EVALUATION OF SUSTAINED RELEASE

TABLET OF NIFEDIPINEDR. P. H. PRAJAPATI

211 26-April-2019 172450824001 PATEL RITUBEN JASHVANTBHAI MRW403P 24 245 MPPharmaceutical


STABILITY STUDY OF SULTAMICILLIN AND ITS TABLET

FORMULATION UNDER ACCELERATED AND STRESS

CONDITION

DR. J. B. DAVE

212 29-April-2019 172460824004 PRACHI GUPTA MRW403P 24 246 MPPharmaceutical


A SYSTEMATIC APPROACH TO NEW PRODUCT

INTRODUCTION WITH EMPHASIS ON THE CONTAINMENT

STRATEGIES AND QUALITY RISK MANAGEMENT

DR ANKITA BHAVSAR

213 29-April-2019 172460824002 DESAI PAMIL SHAMJIBHAI MRW403P 24 246 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF STABILITY

INDICATING METHOD FOR ESTIMATION OF RIOCIGUAT IN

BULK AND PHARMACEUTICAL DOSAGE FORM

DR ANKITA BHAVSAR

214 26-April-2019 172470820009 PANDIT VIPULKUMAR DINESHKUMAR MRW403P 20 247 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF BUCCAL FILMS OF

SAXAGLIPTINMR. VIJAY K. PATEL

215 26-April-2019 172470820002 GAJERA KAUSHIKBHAI GHANSHYAMBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORODISPERSIBLE

TABLETS OF PALIPERIDONEMR. ANIL G. RAVAL

216 26-April-2019 172470820003 JOSHI ARJUN LALITBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF SUBLINGUAL FILMS OF

APIXABANDR. YOGESH K. PATEL

217 26-April-2019 172470820007 MEHTA HIR RAJIV KUMAR MRW403P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


GASTRORETENTIVE FLOATING FILMS OF LAFUTIDINEMR. VIJAY K. PATEL

218 26-April-2019 172470820012 SHAH AKASHKUMAR NARESHKUMAR MRW403P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF COLON TARGETED

PELLETS OF BUMADIZONE CALCIUMMR. ANIL G. RAVAL

219 26-April-2019 172470820001 AGRAWAL HIMANSHU GOPALBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


PHYSICOCHEMICAL CHARACTERISATION AND IN VITRO

DISSOLUTION ENHANCEMENT OF AGOMELATINE USING

SOLID DISPERSION METHOD

MR. VIJAY K. PATEL

220 26-April-2019 172470820011 PRAJAPATI KAJALBEN ARVINDBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORALLY

DISINTEGRATING TABLETS OF MIRABEGRONDR. DHARA B. PATEL

221 26-April-2019 172470820013 SHARMA SUNNY SURESHBHAI MRW403P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF CONTROLLED RELEASE

OSMOTIC TABLET OF CARVEDILOL PHOSPHATEMR. ANIL G. RAVAL

222 26-April-2019 172470824001 ANSARI AFSHANNIKHAT AQEELAHMED MRW403P 24 247 MPPharmaceutical



RP-HPLC METHOD FOR ESTIMATION OF SERTACONAZOLE

NITRATE AND BECLOMETHASONE DIPROPIONATE IN CREAM

MS. ANKITA S. PATEL

223 26-April-2019 172470824002 DHARU NEETUKUMARI RAJESHBHAI MRW403P 24 247 MPPharmaceutical



RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF MS. KUNJAL L. VEGAD

224 26-April-2019 172470824003 HARDIK KIRTIKUMAR BHAVSAR MRW403P 24 247 MPPharmaceutical



ASSAY METHOD FOR ESTIMATION OF TAMSULOSIN DR. VINAY C. DARJI

225 26-April-2019 172470824008 PATEL RINKAL MUKESHBHAI MRW403P 24 247 MPPharmaceutical



AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF MR. KAUSHIK R. PATEL

226 26-April-2019 172470824011 PATIL POOJA SATISHBHAI MRW403P 24 247 MPPharmaceutical



RP-HPLC METHOD FOR ESTIMATION OF MICONAZOLE

NITRATE AND HYDROCORTISONE IN CREAM

DR. VINAY C. DARJI

227 26-April-2019 172470824012 Rathod Jinal Harshadkumar MRW403P 24 247 MPPharmaceutical




CLOTRIMAZOLE, CLINDAMYCIN PHOSPHATE AND

MR. JAYMIN G. PATEL

228 26-April-2019 172470824004 MEGHA JINAL MUKESHBHAI MRW403P 24 247 MPPharmaceutical



STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION

OF BENIDIPINE HCL, TELMISARTAN AND CHLORTHALIDONE

MS. ANKITA S. PATEL

229 26-April-2019 172470824006 PATEL DHARABEN BHARATKUMAR MRW403P 24 247 MPPharmaceutical




OF PARACETAMOL AND ZALTOPROFEN IN TABLET

MR. KAUSHIK R. PATEL

230 26-April-2019 172470824007 PATEL POOJABEN AJAYBHAI MRW403P 24 247 MPPharmaceutical




OF BRINZOLAMIDE AND BRIMONIDINE TARTRATE IN

OPHTHALMIC SUSPENSION

DR. VINAY C. DARJI

231 26-April-2019 172470824009 PATEL SEEMA NITINBHAI MRW403P 24 247 MPPharmaceutical




OF AMLODIPINE BESYLATE AND CELECOXIB IN SYNTHETIC

MIXTURE

MS. BHUMI R. PATEL

232 26-April-2019 172470824010 PATEL UPASANA KANTILAL MRW403P 24 247 MPPharmaceutical




OF MEROPENEM AND VABORBACTAM IN SYNTHETIC

MIXTURE

MR. JAYMIN G. PATEL

233 26-April-2019 172470824015 VYAS KAJAL SHAILESHKUMAR MRW403P 24 247 MPPharmaceutical




FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE IN

MS. ANKITA S. PATEL

234 26-April-2019 172470824013 Salunkhe Suchitra Sunil MRW403P 24 247 MPPharmaceutical


PROCESS VALIDATION OF RIFAMPICIN AND ISONIAZID FILM

COATED TABLETSMR.JAYMIN G. PATEL

235 26-April-2019 172470824014 VAGH VIRAL VITTHALBHAI MRW403P 24 247 MPPharmaceutical


PROCESS OPTIMIZATION AND PROCESS VALIDATION OF

MYOINOSITOL AND D-CHIRO INOSITOL FILM COATED

TABLET

MS. BHUMI R. PATEL

236 26-April-2019 162470804013 patel nikita mahendrabhai 940104 04 247 MPQUALITY

ASSURANCE

STABILITY INDICATING RP-HPLC METHOD METHOD

DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS

ESTIMATION OF TICLOPIDINE AND ASPIRIN IN ITS


Mr.Jaymin G.Patel

237 26-April-2019 172520820001 BULA SANA MOHAMMADHUSAIN MRW403P 20 252 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT AND CHARACTERIZATION OF FLOATING-

MUCOADHESIVE TABLET CONTAINING QUETIAPINE

FUMARATE

DR ALPESH D PATEL

238 01-May-2019 172540820002 Gangat Asma Abdulsattar MRW403P 20 254 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FABRICATION AND CHARACTERIZATION OF LULICONAZOLE

FILM-FORMING TOPICAL SPRAY FOR THE TREATMENT OF

FUNGAL INFECTION

DR. BHAVESH AKBARI

239 01-May-2019 172540820001 CHAUHAN RISHABH HEMANTKUMAR MRW403P 20 254 MP PharmaceuticsNANO SUSPENSION/EMULSION,


DEVELOPMENT AND EVALUATION OF GELATIN TREATED

ACECLOFENAC LOADED EUDRAGIT RS 100

NANOSUSPENSION FOR OSTEOARTHRITIS TREATMENT

DR. MANISH GOYANI

240 01-May-2019 172540820003VARADE SNEHALKUMARI

MADHUKARBHAIMRW403P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY)

PREPARATION AND CHARACTERIZATION OF SPHERICAL

AGGLOMERATES OF LORATADINE TO IMPROVE

DISSOLUTION RATE AND MICROMERITIC PROPERTIES

DR. BHAVESH AKBARI

241 01-May-2019 172540824001 ANCY MATHEW MRW403P 24 254 MPPharmaceutical



FOR THE ESTIMATION OF VORTIOXETINE AND ARIPIPRAZOLE

IN SYNTHETIC MIXTURE

DR. SURESH KUMAR

242 01-May-2019 172540824002 Jangra Sandeepkumar Parasram MRW403P 24 254 MPPharmaceutical



FOR THE ESTIMATION OF MIRABEGRON AND SOLIFENACIN

SUCCINATE IN SYNTHETIC MIXTURE

DR. SURESH KUMAR

243 01-May-2019 172540824003 MAHIDA KAJAL RAKESHKUMAR MRW403P 24 254 MPPharmaceutical



FOR THE ESTIMATION OF DOXOFYLLINE AND ERDOSTEINE IN

SYNTHETIC MIXTURE

DR. SURESH KUMAR

244 01-May-2019 172540824005 PATEL HINAL HARISHBHAI MRW403P 24 254 MPPharmaceutical



SIMULTANEOUS ESTIMATION OF PREGABALIN AND

MELOXICAM IN BINARY MIXTURE

MR. ROHAN BARSE

245 01-May-2019 172540824006 VARACHHIYA HIRAL JASVANTSINH MRW403P 24 254 MPPharmaceutical



FOR THE ESTIMATION OF ITOPRIDE HYDROCHLORIDE AND

OMEPRAZOLE IN SYNTHETIC MIXTURE

MR. ROHAN BARSE

246 02-May-2019 172540825001 CHAUHAN VATSALSINH RAJENDRASINH MRW403P 25 254 MP Pharmacology CNS DISORDER

pharmacological evaluation of Operculina turpethum root

extract in scopolamine-induced cognitive impairments in

rats.

DR. PALLAVI K.J

247 02-May-2019 172540825003 PARMAR JANHAVI ANILKUMAR MRW403P 25 254 MP Pharmacology CNS DISORDER

pharmacological evaluation of Anti-inflammatory & Anti-

nociceptive activities of Doronicum hookeri root extract in

rats

DR. PALLAVI K.J

248 02-May-2019 172540825004 SHAIKH ZEBABIBI ZAHIR MRW403P 25 254 MP Pharmacology CNS DISORDERpharmacological evaluation of Antidepressant activity of

Vigna radiata seed extract in rats.DR. PALLAVI K.J

249 01-May-2019 172540824004 Mandloi Nikita Rampalsingh MRW403P 24 254 MPPharmaceutical


ANALYTICAL METHODS DEVELOPMENT AND ITS VALIDATION

FOR THE ESTIMATION OF TENELIGLIPTIN HYDROBROMIDE

HYDRATE AND GLIMEPIRIDE IN SYNTHETIC MIXTURE

DR. SURESH KUMAR

250 30-April-2019 172540822004 PATEL SAMEERA SULEMAN MRW403P 22 254 MPPharmaceutical

ChemistryMEDICINAL CHEMISTRY

SYNTHESIS AND EVALUATION OF NEW 7-HYDROXY

COUMARIN DERIVATIVES AS ANTI- ALZHEIMER AGENTSDR. MORE UTTAM

251 30-April-2019 172540822001 DHARASANDIYA ARZOO PRABHUDAS MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW BRIDGEHEAD NITROGEN HETEROCYCLES

AS POTENTIAL ANTICANCER AGENTSDR. M. N. NOOLVI

252 30-April-2019 172540822002 JOSHI NIDHIBEN BHASKARBHAI MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW QUINAZOLINE DERIVATIVES AS

ANTICANCER AGENTSMS. MONIKA KAKADIYA

253 30-April-2019 172540822003 MOGAL AZMIN MAHERVAN MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW TAMOXIFEN ANALOGUES AS POTENTIAL

ANTICANCER AGENTSDR. M. N. NOOLVI

254 30-April-2019 172540822005 PATEL ZOFINA IKBAL MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW CANTHARIDIN DERIVATIVES AS

POTENTIAL ANTICANCER AGENTSDR. M. N. NOOLVI

255 30-April-2019 172540822007 Rahevar Vidhikumari Bhupeshkumar MRW403P 22 254 MPPharmaceutical


SYNTHESIS AND EVALUATION OF NEW FLAVONOID

DERIVATIVES AS ANTI-ALZHEIMER AGENTSDR. MORE UTTAM

256 30-April-2019 172540822008 SINGH RAMIYA TILAKDHARI MRW403P 22 254 MPPharmaceutical


SYNTHESIS OF NEW QUINOLINE DERIVATIVES AS

ANTITUBERCULAR AGENTSMS. MONIKA KAKADIYA

257 30-April-2019 172540822009 Zalavadiya Vivek Sureshbhai MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW CHROMAN-4-ONE DERIVATIVES AS

POTENTIAL ANTICANCER AGENTSDR. M. N. NOOLVI

258 25-April-2019 172600820001 ANKIT SINGH KUSHWAH MRW403P 20 260 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DEVELOPMENT, OPTIMIZATION AND EVALUATION OF

EXTENDED RELEASE TABLET OF PALIPERIDONEDR. KUNAL N. PATEL

259 25-April-2019 172600820004 PATEL KRUSHIKA JAGDISHKUMAR MRW403P 20 260 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF MOUTH DISSOLVING

FILM OF FEXOFENADINE HYDROCHLORIDEDR. KUNAL N. PATEL

260 26-April-2019 172600824005 PATEL AISHWARYA JITENDRA MRW403P 24 260 MPPharmaceutical

Quality AssuranceDISSOLUTION STUDIES

DEVELOPMENT AND VALIDATION OF DISSOLUTION TEST

METHOD FOR FLUNARIZINE, DOMPERIDONE AND

PARACETAMOL IN PHARMACEUTICAL DOSAGE FORM

DR. CHIRAG J. PATEL

261 25-April-2019 172600824001 BAMBHROLIYA VIREN GHANSHYAMBHAI MRW403P 24 260 MPPharmaceutical



FOR ESTIMATION OF FLUTICASONE IN HUMAN PLASMA BY

LC-MS/MS

DR. CHIRAG J. PATEL

262 25-April-2019 172600824004 PANCHAL SHIVANI HITESHKUMAR MRW403P 24 260 MPPharmaceutical



ASSAY METHOD FOR ESTIMATION OF TOFACITINIB IN DR. CHIRAG J. PATEL

263 25-April-2019 172600824006 PATEL DIMPLE NATVARLAL MRW403P 24 260 MPPharmaceutical


METHOD DEVELOPMENT AND VALIDATION BY

CHROMATOGRAPHIC METHOD FOR DETERMINATION OF DR. CHIRAG J. PATEL

264 26-April-2019 172600824007 THAKKER KRINA SURESHKUMAR MRW403P 24 260 MPPharmaceutical


PROCESS VALIDATION OF OPTIMIZED FORMULATION OF

VENLAFAXINE HYDROCHLORIDE 37.5 MG TABLET DOSAGE

FORM

DR. CHIRAG J. PATEL

265 25-April-2019 172620820002 PARMAR MADHAVSINH VIJAYBHAI MRW403P 20 262 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND CHARACTERIZATION OF MOUTH

DISSOLVING TABLETS OF VILAZODONE HCL PROF. RAVI V. PATEL

266 25-April-2019 172620820004 PRAJAPATI RINKUBEN ASHOKBHAI MRW403P 20 262 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND OPTIMIZATION OF SUSTAINED RELEASE

DRUG DELIVERY SYSTEM OF SOFOSBUVIR PROF. BHUMI RAVAL

267 25-April-2019 172620820005 SHAH AMIBEN MAHESHKUMAR MRW403P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND CHARACTERIZATION OF FAST

DISSOLVING TABLETS OF LINAGLIPTIN- AN ANTI-DIABETIC

AGENT

PROF. SURAJ R. CHAUHAN

268 25-April-2019 172620820006 SHUKLA ABHAYKUMAR SANTOSH MRW403P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND OPTIMIZATION OF ORAL

DISINTEGRATING STRIPS OF TENELIGLIPTIN FOR THE

TREATMENT OF TYPE II DIABETES

PROF. RAVI V. PATEL

269 25-April-2019 172620820001 BACHANI KOMAL KANAIYALAL MRW403P 20 262 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF TRANSDERMAL

PATCHES OF ADEFOVIR DIPIVOXIL FOR THE TREATMENT OF

HEPATITIS B

PROF. BHUMI RAVAL

270 25-April-2019 172620824001 BASITA NIKHIL CHAMPAKBHAI MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF PIOGLITAZONE

HYDROCHLORIDE AND VILDAGLIPTIN IN SYNTHETIC

MIXTURE

DR. JITENDRA O.

BHANGALE

271 25-April-2019 172620824002 DAVE MANSIBEN SHIRISHKUMAR MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF LOSARTAN

POTASSIUM AND ROSUVASTATIN CALCIUM IN SYNTHETIC

DR. JITENDRA O.

BHANGALE

272 25-April-2019 172620824009 PATEL HIRAL ASHOKBHAI MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF RAMIPRIL AND

SIMVASTATIN IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

273 25-April-2019 172620824011 SONARA KAJAL HARIBHAI MRW403P 24 262 MPPharmaceutical



FOR SIMULTANEOUS ESTIMATION OF REPAGLINIDE AND

SITAGLIPTIN PHOSPHATE IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

274 25-April-2019 172620824003 HIMANI RAJESHKUMAR SAVANI MRW403P 24 262 MPPharmaceutical



SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND

PIOGLITAZONE HYDROCHLORIDE IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

275 25-April-2019 172620824004 MOURYA POONAM GHANSHYAMBHAI MRW403P 24 262 MPPharmaceutical



SIMULTANEOUS ESTIMATION OF LISINOPRIL AND LOSARTAN

POTASSIUM IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

276 25-April-2019 172620824008 PATEL DIVYABEN VIRCHANDBHAI MRW403P 24 262 MPPharmaceutical


METHOD DEVELOPMENT AND VALIDATION OF LEVODOPA

AND BENSERAZIDE IN ORAL DISPERSIBLE TABLET BY RP-HPLC

METHOD

DR JITENDRA O. BHANGALE

277 25-April-2019 172620824010 Saini Ravi bhanwarlal MRW403P 24 262 MPPharmaceutical



SIMULTANEOUS ESTIMATION OF VILDAGLIPTIN AND

NATEGLINIDE IN SYNTHETIC MIXTURE

DR JITENDRA O. BHANGALE

278 25-April-2019 172620824012 TRIVEDI FORAM DHARMENDRABHAI MRW403P 24 262 MPPharmaceutical



SIMULTANEOUS ESTIMATION OF NEBIVOLOL

HYDROCHLORIDE AND LISINOPRIL IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

279 25-April-2019 172620824006 PATEL BINAL NARESHBHAI MRW403P 24 262 MPPharmaceutical



IMPURITY PROFILE OF CITICOLINE SODIUM IN TABLET

DOSAGE FORM

DR. JITENDRA O.

BHANGALE

280 30-April-2019 172630824001 PATEL SAPANA JOITARAM MRW403P 24 263 MPPharmaceutical


RP-HPLC METHOD FOR DETERMINATION OF ADAPALENE

USING CENTRAL COMPOSITE DESIGN DR. PARULA PATEL

281 30-April-2019 172640820003 GADHVI SIDDHI SANJAYDAN MRW403P 20 264 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORO DISPERSIBLE

TABLETS OF ONDANSETRON HYDROCHLORIDE

MS. DHARMISHTHA A.

MOVALIA

282 01-May-2019 172650820001 BARIA ROHANKUMAR PANKAJKUMAR MRW403P 20 265 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



MATRIX TABLETS OF DARIFENACIN HYDROBROMIDEMRS.ANKITA J.PATEL

283 01-May-2019 172650820005 KANZARIA JALPA HASMUKHBHAI MRW403P 20 265 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,


FORMULATION DEVELOPMENT AND EVALUATION OF NASAL

IN SITU GEL OF ANTIEPILEPTIC DRUGDR. ANURADHA PRAJAPATI

284 01-May-2019 172650820008 PATEL MANSVIBEN SURESHBHAI MRW403P 20 265 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU


EXTENDED RELEASE DRUG DELIVERY SYSTEM OF

LUBIPROSTONE

MR. AJAY TALELE

285 01-May-2019 172650820007 PATEL ARMY PRAKASHBHAI MRW403P 20 265 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



SUBLINGUAL TABLET CONTAINING NISOLDIPINEDR.ANURADHA PRAJAPATI

286 01-May-2019 172650820003 HALPATI HEMANGINIBEN AMRUTBHAI MRW403P 20 265 MP PharmaceuticsNANO SUSPENSION/EMULSION,


FORMULATION AND EVALUATION OF AZELAIC ACID

EMULGEL FOR ACNE & HYPERPIGMENTATION TREATMENTMRS.ANKITA JAY PATEL

287 01-May-2019 172650824001 BHADRA RINKALBEN MAHESHBHAI MRW403P 24 265 MPPharmaceutical



FOR ESTIMATION OF PRIMIDONE IN K3EDTA HUMAN


DR.SHAILESH LUHAR

288 01-May-2019 172650824003 KHETIYA MEGHA MANOJBHAI MRW403P 24 265 MPPharmaceutical



FOR ESTIMATION OF PAROXETINE HYDROCHLORIDE IN

K3EDTA HUMAN PLASMA BY USING LC-ESI-MS/MS

DR. SACHIN BHASKAR

NARKHEDE

289 01-May-2019 172650824006 PRAJAPATI HIRAL ARVINDBHAI MRW403P 24 265 MPPharmaceutical



FOR ESTIMATION OF ATAZANAVIR IN K3EDTA HUMAN DR. CHIRAG DESAI

290 01-May-2019 172650824007 RATHOD SHEETAL JAGDISHCHANDRA MRW403P 24 265 MPPharmaceutical



FOR ESTIMATION OF NINTEDANIB IN K3EDTA HUMAN

PLASMA BY USING LC-APCI-MS/MS

DR.SHAILESH LUHAR

291 01-May-2019 172650824002 DHUMAL SHRADDHA SURESH MRW403P 24 265 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR

SIMULTANEOUS ESTIMATION OF OFLOXACIN,

CLOTRIMAZOLE AND ORNIDAZOLE IN THEIR COMBINED

DOSAGE FORM

DR. DULENDRA P. DAMAHE

292 01-May-2019 172650824008 SINGH NEHA PRAMOD MRW403P 24 265 MPPharmaceutical



SIMULTANEOUS ESTIMATION OF OFLOXACIN, ORNIDAZOLE

AND RACECADOTRIL IN PHARMACEUTICAL DOSAGE FORM

DR. DULENDRA P. DAMAHE

293 02-May-2019 172680825003 PATEL PINESHKUMAR SURESHBHAI MRW403P 25 268 MP PharmacologyRESPIRATORY DISORDER ( PLEASE

SPECIFY DISORDER OR

EVALUATION OF ANTIASTHAMATIC ACTIVITY OF ETHANOLIC

EXTRACT OF LUFFA ECHINATA ROXB. FRUITSMR. VIPUL GAJERA

294 02-May-2019 172680825002 PARMAR POOJA SURESHCHANDRA MRW403P 25 268 MP Pharmacology OTHER (KINDLY SPECIFY)

EVALUATION OF ANTI-ARTHRITIC ACTIVITY OF BLUMEA

BALSAMIFERA (L.) DC. IN EXPERIMENTALLY INDUCED

ARTHRITIS IN RATS.

MR. VIPUL GAJERA

295 02-May-2019 172680825001 MISTRY SHIVANGIBEN NARESHKUMAR MRW403P 25 268 MP PharmacologyMETABOLIC DISORDER ( PLEASE

SPECIFY DISORDER)

EVALUATION OF ANTIDIABETIC POTENTIAL OF LUFFA

ECHINATA ROXB. IN WISTAR RATSDR. VIJAY LAMBOLE

296 01-May-2019 172680824001 PARMAR VIRANCHI JITENDRASINH MRW403P 24 268 MPPharmaceutical



RP-HPLC METHOD FOR ESTIMATION OF VORTIOXETINE

HYDROBROMIDE IN PHARMACEUTICAL DOSAGE FORM.

MR. SAGARKUMAR P.

PATEL

297 02-May-2019 172680825004 PATEL SHITALBEN RAJUBHAI MRW403P 25 268 MP PharmacologyG.I. TRACT ( PLEASE SPECIFY

DISORDER OR DISEASE)

EFFECT OF COMBINED EXTRACT OF CORDIA DICHOTOMA

FORST. AND AEGLE MARMELOS CORR. IN EXPERIMENTAL

MODELS OF PEPTIC ULCER

DR. VIJAY LAMBOLE

298 30-April-2019 172690820001 Bhuva Mitalben Dineshbhai MRW403P 20 269 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN, FORMULATION AND EVALUATION OF PRESS

COATED PULSATILE DRUG DELIVERY SYSTEM OF AZILSARTAN

MEDOXOMIL TABLET

MISS. SHEETAL

BUDDHADEV

299 30-April-2019 172690820004 Raninga Tushar Kishorbhai MRW403P 20 269 MP PharmaceuticsDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

DESIGN, DEVELOPMENT AND EVALUTION OF BILAYER

TABLET OF PIOGLITAZONE AND PHENFORMIN FOR

EXTENDED RELEASE SYSTEM

SHEETAL BUDDHADEV

300 26-April-2019 172780820005 SOLANKI ARTI NARENDRASINH MRW403P 20 278 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,



BUCCAL TABLETS OF ZOLPIDEM TARTRATEDR. KINJAL SOLANKI

301 26-April-2019 172780820001 DALBANJAN NIKITA SURESHBHAI MRW403P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST



TABLETS OF TELMISARTANDR. VIKRAM PANDYA

302 26-April-2019 172780820003 PANDIT MRUGESH SURESHBHAI MRW403P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF FAST DISSOLVING

FILMS OF LINAGLIPTINDR. VIKRAM PANDYA

303 26-April-2019 172780824004 PATEL HARSHITKUMAR PANKAJBHAI MRW403P 24 278 MPPharmaceutical



FOR THE SIMULTANEOUS ESTIMATION OF FLUCONAZOLE

AND BECLOMETHASONE DIPROPIONATE IN COMBINED


DR RAJESH K PATEL

304 26-April-2019 172780824005 PATEL HINAL BALDEVBHAI MRW403P 24 278 MPPharmaceutical



FOR THE SIMULTANEOUS ESTIMATION OF

DEXCHLOPHENIRAMINE MELEATE AND BETAMETHASONE IN

DR MITALI SHRIMANKER

305 26-April-2019 172780824006 PUJARA DISHA KIRITKUMAR MRW403P 24 278 MPPharmaceutical



FOR THE SIMULTANEOUS ESTIMATION OF AMBROXOL

HYDROCHLORIDE AND GUAIFENESIN IN HUMAN PLASMA BY

USING LC-MS/MS

DR KINJAL SOLANKI

306 26-April-2019 172780824008 THAKKAR BHOOMIBEN HASMUKHBHAI MRW403P 24 278 MPPharmaceutical


BIO ANALYTICAL METHOD DEVELOPMENT AND VALIDATION

FOR THE SIMULTANEOUS ESTIMATION OF SOFOSBUVIR AND

LEDIPASVIR IN HUMAN PLASMA BY LC-ESI-MS/MS

DR RAJESH K PATEL

307 26-April-2019 172780824003 KHATRI HEMAXI DEVENDRAKUMAR MRW403P 24 278 MPPharmaceutical


ANNUAL PRODUCT QUALITY REVIEW (APQR) OF LOSARTAN

TABLETS 100 MGDR VIKRAM PANDYA

308 02-May-2019 172820829002 MONA HITESHKUMAR SUTHAR MRW403P 29 282 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)

EVALUATION OF RATIONALITY OF ANTIMICROBIAL AND

ANTIDIARRHEAL FIX DOSE COMBINATION USED IN INDIAN

POPLUTION

DR. HETAL D. SOLANKI

309 02-May-2019 172820829003 PARMAR HEMAKSHIBEN RAMANBHAI MRW403P 29 282 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)

KNOWLEDGE AND PRACTICES OF ANTIBIOTICS SELF-

MEDICATION AMONG HEALTHCARE PROFESSIONAL

STUDENTS IN GUJARAT

DR. HETAL D. SOLANKI

310 30-April-2019 172820824001 PATEL BIRAJKUMAR VIJAYBHAI MRW403P 24 282 MPPharmaceutical



RP-HPLC METHOD FOR FLUCONAZOLE AND

BECLOMETHASONE IN ITS COMBINED DOSAGE FORM

DR. M.B. SHANKAR

311 30-April-2019 172820824002 PATEL SUNNY HEMANTKUMAR MRW403P 24 282 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF LIQUID

CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS

ESTIMATION OF DOXOPHYLLINE AND ACEBROPHYLLINE IN

DR. M.B.SHANKAR

312 25-April-2019 172860824001 kunal Bhatt MRW403P 24 286 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF BIOANALYTICAL

METHOD FOR DETERMINATION OF CLOMIPRAMINE AND N-

DESMETHYL CLOMIPRAMINE FROM K3 EDTA HUMAN

DR. MANDEV B. PATEL

313 25-April-2019 172860824002 Kuntalkumar maheshbhai prajapati MRW403P 24 286 MPPharmaceutical



METHOD FOR DETERMINATION OF AMBRISENTAN FROM K3

EDTA HUMAN PLASMA USING LC-MS/MS.

DR. MANDEV B. PATEL

314 25-April-2019 172860824007 Prajapati Kinnari Dasharathbhai MRW403P 24 286 MPPharmaceutical



MEHTHOD FOR DETERMINATION OF DEFERASIROX FROM

HUMAN PLASMA USING LC-MS/MS.

MS. MINAKSHI DHORU

315 25-April-2019 172860824009 Shah Kajal Rajendrabhai MRW403P 24 286 MPPharmaceutical



METHOD FOR DETERMINATION OF EXEMESTANE FROM K3

EDTA HUMAN PLASMA USING LC-MS/MS

MS. MINAKSHI DHORU

316 25-April-2019 172860824014 vikas pal MRW403P 24 286 MPPharmaceutical



METHODS FOR DETERMINATION OF PROPAFENONE AND 5-

HYDROXYPROPAFENONE FROM K3 EDTA HUMAN PLASMA

DR. MANDEV B. PATEL

317 26-April-2019 172860824005 Pandya Shivangi Krupeshchandra MRW403P 24 286 MPPharmaceutical



FOR DETERMINATION OF DILTIAZEM MALEATE AND

ENALAPRIL MALEATE FROM ITS FIXED DOSE COMBINATION

DR. PINAK R. PATEL

318 26-April-2019 172860824011 Shukla Rashmi Rammilan MRW403P 24 286 MPPharmaceutical



FOR DETERMINATION OF RIVAROXABAN AND ASPIRIN FROM

SYNTHETIC MIXTURE.

DR. PINAK R. PATEL

319 26-April-2019 172860824012 Sirsiker bhumi prashantbhai MRW403P 24 286 MPPharmaceutical



FOR DETERMINATION OF TOBRAMYCIN AND

FLUOROMETHOLONE ACETATE FROM OPTHALMIC

FORMULATION

DR. PINAK R. PATEL

320 25-April-2019 172860824003 MAKWANA HEMANGIBEN SHASHIKANT MRW403P 24 286 MPPharmaceutical



RP-HPLC METHOD FOR DETERMINATION OF EFONIDIPINE

HYDROCHLORIDE ETHANOLATE IN BULK AND TABLET

DOSAGE FORM.

MRS. BINNY D. MEHTA

321 25-April-2019 172860824008 sangale Hemangi Shivji MRW403P 24 286 MPPharmaceutical



RP-HPLC METHOD FOR DETERMINATION OF MIRABEGRON

FROM ITS PHARMACEUTICAL FORMULATION

MRS. BINNY D. MEHTA

322 26-April-2019 172860824013 Vasani Priyanka sureshbhai MRW403P 24 286 MPPharmaceutical



FOR DETERMINATION OF PAMABROM AND NSAIDs IN

COMBINATION

DR. PINAK R. PATEL

323 29-April-2019 172880827001 Ansari Daraksha Muhammad MRW403P 27 288 MPPharmaceutical


A STUDY ON REGISTRATION PROCESS FOR MOISTURIZING

CREAM AND ANTI-ACNE CREAM IN INDIA, USA, EUROPEAN

UNION COUNTRIES, TANZANIA AND ETHIOPIA

MR. FENIL SHAH

324 29-April-2019 172880827002 BATADA NORIN BARKATBHAI MRW403P 27 288 MPPharmaceutical


COMPARISON OF REGULATORY REQUIREMENTS AS PER

USFDA & EMA FOR IMMEDIATE RELEASE AND EXTENDED

RELEASE ORAL FORMULATIONS AND COMPILATION OF

MODULE 3 AND 5 AS PER EMA

MR. NAGESH NANDA

325 29-April-2019 172880827004 GANDHI HANSAL VIJAY MRW403P 27 288 MPPharmaceutical


A STUDY ON REGISTRATION PROCESS OF GENERIC

BUDESONIDE DRY POWDER INHALER AS PER USFDA

GUIDANCE

DR. RAJESH PARIKH

326 29-April-2019 172880827005 GOHEL SAGAR KISHORBHAI MRW403P 27 288 MPPharmaceutical


A STUDY ON SUMMARY TECHNICAL DOCUMENTATION

(STED) FOR TRANSCATHETER SEPTAL OCCLUDER AS PER

INTERNATIONAL MEDICAL DEVICE REGULATORS FORUM

(IMDRF)

DR. ANAND SHAH

327 29-April-2019 172880827006 JADAV RAHUL KIRITKUMAR MRW403P 27 288 MPPharmaceutical


A STUDY ON REGULATORY REQUIREMENTS TO PREVENT

COUNTERFEIT DRUGS IN USA, EUROPE & INDIAMR. NIRAV CHOKSHI

328 29-April-2019 172880827007 JAGANI DHARMESHKUMAR UKABHAI MRW403P 27 288 MPPharmaceutical


PREPARATION OF DRAFT ABBREVIATED NEW DRUG

APPLICATION (ANDA) FOR OSELTAMIVIR CAPSULE AS PER

USFDA

DR. ANAD SHAH

329 29-April-2019 172880827008 PATEL PANKTIBEN KIRTIKUMAR MRW403P 27 288 MPPharmaceutical


COMPARISON OF REGULATORY REQUIREMENTS AS PER

USFDA & EMA FOR DELAYED RELEASE AND EXTENDED

RELEASE ORAL FORMULATIONS AND COMPILATION OF

MR. KASHYAP THUMMAR

330 29-April-2019 172880827009 PATEL YAGNESHKUMAR VINODBHAI MRW403P 27 288 MPPharmaceutical


A STUDY ON REGISTRATION PROCESS OF RITUXIMAB

INJECTION -A BIOSIMILAR PRODUCT TO MabThera® AS PER

EMA

MR. FENIL SHAH

331 29-April-2019 172880827010 Shipra Vijayesh Pandey MRW403P 27 288 MPPharmaceutical


NALOXONE HCL NASAL SPRAY : DRAFT DOSSIER

PREPARATION FOR ANDS AS PER HEALTH CANADADR. ANAND SHAH

332 29-April-2019 172880827011 THAKKAR RAGHAV ATMARAMBHAI MRW403P 27 288 MPPharmaceutical


REGULATORY CONSIDERATION FOR IMPORT &

REGISTRATION OF HEMODIALYSER IN INDIA & EXPORT IN

MEMBER COUNTRIES OF ASEAN

MR. KASHYAP THUMMAR

333 29-April-2019 172880827003 DEVADHA MEHULBHAI RAJNIKANT MRW403P 27 288 MPPharmaceutical


REGISTRATION OF AMLODIPINE TABLET IN USA & EU

COUNTRIES AND IMPLICATIONS FOR CHANGE IN EXCIPIENT

CONCENTRATION

DR. RAJESH PARIKH

334 30-April-2019 142240808013 PATEL VIVEK GANPATBHAI 940102 08 224 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST

DISPERSIBLE/DISSOLVING


FILM OF ENALAPRIL MALEATEMRS SEJAL SOLANKI

335 25-April-2019 162240808010 PATEL PANKIL LALITBHAI 940102 08 224 MP PHARMACEUTICSDELAYED/EXTENDED RELEASE,

FLOATING, INSITU

FORMULATION AND EVALUATION OF SUBLINUAL TABLET OF

APREMILASTMR JAYANTI BAJAG

336 26-April-2019 162250808015 PATEL ROMA BHARATKUMAR 940102 08 225 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORALLY

DISINTEGRATING TABLET OF TRIMEPRAZINEDR. SHAILESH T. PRAJAPATI

337 30-April-2019 162250808018 YOGENDRAKUMAR TIRATHRAJ MISHRA 940102 08 225 MP PHARMACEUTICSBUCO/MUCOADHESIVE, TDDS,


FORMULATION AND EVALUATION OF BUCCAL FILM OF

PRAZOCIN HYDROCHLORIDEDR. HEMANGI J. PATEL

338 26-April-2019 162470808006 PATEL VIJAYKUMAR JAYANTIBHAI 940102 08 247 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST



MATRIX TABLETS OF PRAZOSIN HYDROCHLORIDEMR.ANIL RAVAL

339 26-April-2019 162520804003 PATEL JALAK VINUBHAI 940104 04 252 MPQUALITY

ASSURANCESTABILITY STUDIES


HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF

BENIDIPINE HCI AND CHLORTHALIDONE IN TABLET

MR M L KHARODIYA

340 26-April-2019 162560804005 PATEL DHAVAL SURESHBHAI 940104 04 256 MPQUALITY

ASSURANCESIMULTENEOUS ESTIMATION

DEVELOPMENT AND VALIDATION OF UV AND RP-HPLC

METHOD FOR SIMULTANEOUS ESTIMATION OF SAQUINAVIR

DRUG IN BULK AND PHARMACEUTICAL DOSAGE FORM

DR. BIRAJUBEN PATEL

341 30-April-2019 162640808007 TANK NITIN RAMESHBHAI 940102 08 264 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF QUICK DISSOLVING

FILM OF VENLAFAXINE HCI USING NATURAL

POLYSACCHARIDES

MS. DHARMISHTHA A.

MOVALIA

Date post:	21-Nov-2021
Category:	Documents
Upload:	others
View:	5 times
Download:	0 times

Gujarat Technological University Student list for M.Pharm ...

Documents